Macromolecular Interactions of t-Darpp and Darpp-32
Macromolecular Interactions of t-Darpp and Darpp-32
批准号:
8487826
负责人:
SUSAN E KANE
金额:
$32.44万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2018-07-31
关键词:
AddressAffectAffinityAffinity ChromatographyBindingBiological AssayBiosensorCancer cell lineCell ProliferationCellsCellular biologyComplexConfocal MicroscopyCultured CellsCyclic AMP-Dependent Protein KinasesCytostaticsCytotoxic agentDevelopmentDissociationDominant-Negative MutationDrug resistanceEpitopesEquilibriumFluorescence Resonance Energy TransferFutureGrowthImageImmunoprecipitationInvestigationKnowledgeLifeMalignant NeoplasmsMapsMass Spectrum AnalysisMediatingMolecularMolecular BiologyMutateN-terminalNeurogliaNeuronsNormal CellNormal tissue morphologyPathway interactionsPhasePhenotypePhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesProtein BindingProtein BiochemistryProtein IsoformsProtein phosphataseProteinsProteomicsPublishingRecombinantsRegulationResearchResearch PersonnelResistanceRoleSchemeSignal TransductionStructureSurface Plasmon ResonanceWorkbasebiophysical techniquescell growthcell motilitycell typeinhibitor/antagonistinnovationinsightinterestkinase inhibitormutantneurotransmissionoverexpressionphosphatase inhibitorphysical propertyprotein functionprotein kinase A kinaseprotein protein interactionpublic health relevance
中文摘要
描述(由申请人提供):在研究癌症耐药性的过程中,我们和其他人鉴定了一种称为t-Darpp(tDp)的蛋白质作为耐药表型的关键组分。tDp的正常功能完全未知。Darpp-32(Dp 32)是tDp的较长同种型,其在多巴胺能神经传递中的蛋白激酶A(PKA)信号传导中的作用被充分研究。Dp 32通过蛋白质-蛋白质相互作用起作用;它是一种双功能蛋白,根据Dp 32在残基T34或T75处的磷酸化状态抑制蛋白磷酸酶-1(PP 1)或PKA。它在非神经元细胞中的作用尚不清楚,但有证据表明它可能抑制细胞生长和迁移。我们发表的研究表明,tDp,较短的蛋白质,通过PKA激活(而不是抑制)促进细胞增殖(而不是抑制)。这种效应的分子机制尚未确定,但它可能也通过蛋白质-蛋白质相互作用发挥作用。tDp缺乏与PP 1相互作用所需的N-末端结构域,但T75处的磷酸化(使用Dp 32编号方案)似乎是其促进细胞增殖的活性所需的。因此,Dp 32和tDp似乎对细胞生长和PKA信号传导具有拮抗作用,可能是通过对彼此的大分子相互作用的显性负效应。我们假设tDp、Dp 32和PKA信号网络的物理和功能相互作用有助于确定细胞生长和生长抑制之间的平衡。为了解决这一假设,我们需要更好地了解细胞中Dp 32和tDp的物理相互作用以及这些相互作用与蛋白质功能之间的关系。剖析这些相互作用将需要多个研究人员的贡献,在分子生物学,细胞生物学和蛋白质生物化学的专业知识;当代蛋白质组学策略和生物物理方法的应用;和创新的成像为基础的方法的发展。我们提出了三个具体的目标:1)鉴定细胞裂解物中Dp 32和tDp的功能相关的大分子相互作用; 2)
确定在活细胞中是否发生功能相关的大分子相互作用;和3)确定介导Dp 32和tDp相互作用的物理性质和分子界面。
英文摘要
DESCRIPTION (provided by applicant): In the course of studying drug resistance in cancer, we and others identified a protein called t-Darpp (tDp) as a key component of the resistance phenotype. The normal function of tDp is completely unknown. Darpp-32 (Dp32) is a longer isoform of tDp that is well studied for its role in protein kinase A (PKA) signaling in dopaminergi neurotransmission. Dp32 works by protein-protein interaction; it is a dual-function protein that inhibits either protein phosphatase-1 (PP1) or PKA, depending on Dp32's phosphorylation status at residues T34 or T75. Its role in non-neuronal cells is unclear, but there is evidence to suggest that it might inhibit cell growth and migration. Our published studies suggest that tDp, the shorter protein, promotes cell proliferation (not inhibition) via PKA activation (not inhibitio). The molecular mechanism of this effect has not been determined, but it presumably also functions via protein-protein interaction. tDp lacks the N-terminal domain that is required for interaction with PP1, but phosphorylation at T75 (using the Dp32 numbering scheme) appears to be required for its activity in promoting cell proliferation. Thus, Dp32 and tDp seem to have antagonistic effects on cell growth and on PKA signaling, possibly via dominant-negative effects on each other's macromolecular interactions. We hypothesize that the physical and functional interaction of tDp, Dp32, and the PKA signaling network helps determine the balance between cell growth and growth inhibition. To address this hypothesis we need a greater understanding of Dp32 and tDp physical interactions in cells and the relationship between those interactions and protein function. Dissecting these interactions will require the contribution of multiple investigators with specialized expertise in molecular biology, cell biology, and protein biochemistry; the application of contemporary proteomic strategies and biophysical methods; and the development of innovative imaging-based approaches. We propose three specific aims: 1) Identify functionally- relevant macromolecular interactions for Dp32 and tDp in cell lysates; 2)
Determine if functionally relevant macromolecular interactions occur in live cells; and 3) Determine the physical properties and molecular interfaces mediating Dp32 and tDp interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Macromolecular Interactions of t-Darpp and Darpp-32
-
批准号:9121583
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2014
-
负责人:SUSAN E KANE
-
依托单位:
Macromolecular Interactions of t-Darpp and Darpp-32
-
批准号:8915223
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2014
-
负责人:SUSAN E KANE
-
依托单位:
City of Hope and the San Gabriel Valley SEPA Collaborative
-
批准号:8663331
-
项目类别:
-
资助金额:$26.03万
-
财政年份:2012
-
负责人:SUSAN E KANE
-
依托单位:
City of Hope and the San Gabriel Valley SEPA Collaborative
-
批准号:8841422
-
项目类别:
-
资助金额:$26.3万
-
财政年份:2012
-
负责人:SUSAN E KANE
-
依托单位:
City of Hope and the San Gabriel Valley SEPA Collaborative
-
批准号:8461543
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2012
-
负责人:SUSAN E KANE
-
依托单位:
City of Hope and the San Gabriel Valley SEPA Collaborative
-
批准号:8287938
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2012
-
负责人:SUSAN E KANE
-
依托单位:
City of Hope and the San Gabriel Valley SEPA Collaborative
-
批准号:8717190
-
项目类别:
-
资助金额:$8.49万
-
财政年份:2012
-
负责人:SUSAN E KANE
-
依托单位:
In Vivo Bioimaging Model to Study Inducible Drug Resistance in Cancer
-
批准号:8250403
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2009
-
负责人:SUSAN E KANE
-
依托单位:
In Vivo Bioimaging Model to Study Inducible Drug Resistance in Cancer
-
批准号:8656464
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2009
-
负责人:SUSAN E KANE
-
依托单位:
In Vivo Bioimaging Model to Study Inducible Drug Resistance in Cancer
-
批准号:8458907
-
项目类别:
-
资助金额:$31.41万
-
财政年份:2009
-
负责人:SUSAN E KANE
-
依托单位:
In Vivo Bioimaging Model to Study Inducible Drug Resistance in Cancer
-
批准号:8528759
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2009
-
负责人:SUSAN E KANE
-
依托单位:
In Vivo Bioimaging Model to Study Inducible Drug Resistance in Cancer
-
批准号:7750046
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2009
-
负责人:SUSAN E KANE
-
依托单位:
In Vivo Bioimaging Model to Study Inducible Drug Resistance in Cancer
-
批准号:8061620
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2009
-
负责人:SUSAN E KANE
-
依托单位:
CSULA-COH Collaborative to Study Cancer Disparities
-
批准号:7225749
-
项目类别:
-
资助金额:$26.41万
-
财政年份:2006
-
负责人:SUSAN E KANE
-
依托单位:
CSULA-COH Collaborative to Study Cancer Disparities
-
批准号:7682324
-
项目类别:
-
资助金额:$11.89万
-
财政年份:2006
-
负责人:SUSAN E KANE
-
依托单位:
CSULA-COH Collaborative to Study Cancer Disparities
-
批准号:7486859
-
项目类别:
-
资助金额:$16.07万
-
财政年份:2006
-
负责人:SUSAN E KANE
-
依托单位:
CSULA-COH Collaborative to Study Cancer Disparities
-
批准号:7291675
-
项目类别:
-
资助金额:$23.49万
-
财政年份:2006
-
负责人:SUSAN E KANE
-
依托单位:
MDR1 SELECTION IN CD34+ CELLS AND SCID-HU MICE
-
批准号:2443293
-
项目类别:
-
资助金额:$18.27万
-
财政年份:1996
-
负责人:SUSAN E KANE
-
依托单位:
MDR1 SELECTION IN CD34+ CELLS AND SCID-HU MICE
-
批准号:2733271
-
项目类别:
-
资助金额:$19.01万
-
财政年份:1996
-
负责人:SUSAN E KANE
-
依托单位:
MDR1 GENE THERAPY IN CD34+ CELLS AND SCID MICE
-
批准号:2911359
-
项目类别:
-
资助金额:$27.55万
-
财政年份:1996
-
负责人:SUSAN E KANE
-
依托单位:
海外基金